Lung Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. Lung Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Liquid biopsies improve access to treatment options for many cancers and may replacing tissue tests & diagnostic imaging
Datopotamab is a novel precision medicine known as an antibody drug conjugate that targets HER2 + NSCLC
Alcensa, Xalkori, and several other precision cancer medicines target ALK positive lung cancer and improve treatment.
Research suggests diet and nutrition play in role in reducing the risk of lung cancer.
Development of precision cancer medicines, immunotherapy, genomic testing are proceeding with great speed - Stay Current